α-Lipoic Acid and Cardiovascular Disease

Journal of Nutrition

Volumn 133, Issue 11, 2003, Pages 3327-3330

  Wollin, Stephanie D ^a   Jones, Peter J H ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Antioxidant; Cardiovascular disease; lipoic acid

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; DIHYDROLIPOATE; GLUTATHIONE; LIPID; LOW DENSITY LIPOPROTEIN; REACTIVE OXYGEN METABOLITE; THIOCTIC ACID;

ANTIOXIDANT ACTIVITY; CARDIOVASCULAR DISEASE; DIET SUPPLEMENTATION; HYDROPHILICITY; HYDROPHOBICITY; HYPERTENSION; LIPID BLOOD LEVEL; LIPID OXIDATION; OXIDATIVE STRESS; REVIEW; RISK FACTOR; SOLUBILITY;

EID: 0242661909     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/133.11.3327     Document Type: Review

References (40)

1. Busby, R. W., Schelvis, J.P.M., Yu, D. S., Babcock, G. T. & Marletta, M. A. (1999) Lipoic acid biosynthesis: LipA is an iron-sulphur protein. J. Am. Chem. Soc. 121: 4706-4707.
2. Schmidt, A. M., Hori, O. & Brett, J. (1994) Cellular receptor for advanced glycation end products: implications for induction of oxidative stress and cellular dysfunction in the pathogenesis of vascular lesions. Atheroscler. Thromb. 14: 1521-1528.
3. Reed, L. (1998) From lipoic acid to multi-enzyme complexes. Protein Sci. 7: 220-224.
4. Wada, H., Shintani, D. & Ohlrogge, J. (1997) Why do mitochondria synthesize fatty acids? Evidence for involvement in lipoic acid production. Proc. Natl. Acad. Sci. U.S.A. 94: 1591-1596.
5. Blewenga, G. P., Haenen, G.R.M.M. & Bast, A. (1997) The pharmacology of the antioxidant lipoic acid. Gen. Pharmacol. 29: 315-331.
6. Jones, W., Li, X., Qu, Z., Perriott, L., Whiteshell, R. R. & May, J. M. (2002) Uptake, recycling, and antioxidant actions of α-lipoic acid in endothelial cells. Free Radical Biol. Med. 33: 83-93.
7. Papas, A. M. ed. (1998) Antioxidant Status, Diet, Nutrition, and Health. CRC Press, Boca Raton, FL.
8. Moini, H., Tirosh, O., Park, Y. C., Cho, K.-J. & Packer, L. (2002) R-α-lipoic acid action on cell redox status, the insulin receptor, and glucose uptake in 3T3-L1 adipocytes. Arch. Biochem. Biophys. 397: 384-391.
9. Packer, L., Witt, E. H. & Tritschler, H. (1995) Alpha-lipoic acid as a biological antioxidant. Free Radical Biol. Med. 19: 227-250.
10. Packer, L., Kraemer, K. & Rimbach, G. (2001) Molecular aspects of lipoic acid in the prevention of diabetes complications. Nutrition 17: 888-895.
11. Morikawa, T., Yasuno, R., & Wada, H. (2001) Do animal cells synthesize lipoic acid? Identification of a mouse cDNA encoding a lipoic acid synthase located in mitochondria. Fed. Euro. Biochem. Soc. 498: 16-21.
12. Biewenga G. P., Haenen, G.R.M.M. & Bast, A. (1997) An overview of lipoate chemistry. In: Lipoic Acid in Health and Disease (Fuchs, J., Packer, L. & Zimmer, G., eds.). pp. 1-32. Marcel Dekker, New York.
13. Marquet, A., Tse Sum Bui, B. & Florentin, D. (2001) Biosynthesis of biotin and lipoic acid. Vitam. Horm. 61: 51-94.
14. Evans, J. L. & Goldfine, I. D. (2000) α-Lipoic acid: A multifunctional antioxidant that improves insulin sensitivity in patients with Type II diabetes. Diabetes Tech. Therap. 2: 401-413.
15. Rahnau, K. J., Meissnert, H. P., Finn, J. R., Reljanovic, M., Lobisch, M., Schütte, K., Nehrdich, D., Tritschler, H. J., Mehnert, H. & Ziegler, D. (1999) Effects of 3-week oral treatment with antioxidant thioctic acid (α-lipoic acid) in symptomatic diabetic polyneuropathy. Diabet. Med. 16: 1040-1043.
16. Marangon K., Devaraj, S., Tirosh, O., Packer, L. & Jialal, I. (1999) Comparison of the effect of α-lipoic acid and α-tocopherol supplementation on measures of oxidative stress. Free Radical Biol. Med. 27: 1114-1121.
17. Tiechert, J., Kern, J., Tritschler, H.-J., Ulrich, H. & Preib, R. (1998) Investigations on the pharmacokinetics of α-lipoic acid in healthy volunteers. Int. J. Clin. Pharm. Th. 36: 625-628.
18. Hermann, R., Niebch, G., Borbe, H. O., Fieger-Büschges, H., Ruus, P., Nowak, H., Riethmüller, H., Peukert, M. & Blume, H. (1996) Enantioselective pharmacokinetics and bioavailability of different racemic α-lipoic acid formulations in healthy volunteers. Eur. J. Pharm. Sci. 4: 167-174.
19. Ziegler, D., Reljanovic, M., Mehnert, H. & Gries, F. A. (1999) α-Lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials. Exp. Clin. Endocr. Diab. 107: 421-430.
20. Estrada, E., Ewart, H. S., Tsakiridis, T., Volchuk, A., Ramlal, T., Tritschler, H. & Klip, A. (1996) Stimulation of glucose uptake by the natural coenzyme α-lipoic acid/thioctic acid: participation of elements of the insulin signalling pathway. Diabetes 45: 1798-1805.
21. Kagan, W., Kuklinski, B., Ruhlmann, C., & Plotz, C. (1992) Recycling of vitamin E in human low density lipoproteins. J. Lipid Res. 33: 385-397.
22. Schupke, H., Hempel, R., Peter, G., Hermann, R., Wessel, K., Engel, J. & Kronbach, T. (2001) New metabolic pathways of α-lipoic acid. Drug Metab. Dispos. 29: 855-862.
23. Harrison, E. H. & McCormick, D. B. (1974) The metabolism of dl-[1, 6-14C] lipoic acid in the rat. Arch. Biochem. Biophys. 160: 514-522.
24. Hoffman, M. A., Tritschler, H. J., Bierhaus, A., Zeigler, R., Wahl, P. & Nawroth, P. (2000) Lipoate effects on atherogenesis. In: Lipoic Acid in Health and Disease. (Fuchs, J., Packer, L. & Zimmer, G., eds.). pp. 321-336. Marcel Dekker, New York.
25. Westhuysen, J. (1997) The oxidation hypothesis of atherosclerosis: an update. Ann. Clin. Lab. Sci. 27: 1-10.
26. Tardif, J-C. & Bourassa, M. G., eds. (2000) Developments in Cardiovascular Medicine: Antioxidants and Cardiovascular Disease. v. 233. Kluwer Academic Press, The Netherlands.
27. Forgione, M. & Loscaizo, J. (2000) The antioxidant hypothesis In: Developments in Cardiovascular Medicine: Antioxidants and Cardiovascular Disease (Tardif, J-C. & Bourassa, M. G., eds.) v. 233, pp. 47-57. Kluwer Academic Press, The Netherlands.
28. Leaf, A. & Halleq, H. A. (1992) The role of nutrition in the functioning of the cardiovascular system. Nutr. Rev. 50: 402-406.
29. Christian, W. G. & Hennekens, C. H. (2000) Antioxidant vitamins and cardiovascular disease: Evidence from observational epidemiologic studies and randomized trials. In: Developments in Cardiovascular Medicine: Antioxidants and Cardiovascular Disease. (Tardif, J-C. & Bourassa, M. G., eds) v. 233, pp. 135-145. Kluwer Academic Press; The Netherlands.
30. Stampfer, M. J., Hennekens, C. H., Manson, J. E., Colditz, G. A., Rosner, B. & Willet, W. C. (1993) Vitamin E consumption and the risk of coronary disease in women. New Engl. J. Med. 328: 1444-1449.
31. Rimm, E. B., Stampfer, M. J., Ascherio, A., Giovannucci, E., Colditz, G. A. & Willet, W. C. (1993) Vitamin E consumption and the risk of coronary heart disease in men. New Engl. J. Med. 328: 1450-1456.
32. Lodge, J. K., Traber, M. G. & Packer, L. (1998) Thiol chelation of Cu2+ by dihydrolipoic acid prevents human low density lipoprotein peroxidation. Free Radical Biol. Med. 25: 287-297.
33. Angelucci, L. & Mascitelli-Coriandoli, E. (1958) Anticholesterol activity of α-lipoic acid. Nature 181: 911-12.
34. Kritchevesky, D. (1958) Anticholesterol activity of α-lipoic acid. Nature 182: 396.
35. Ivanov, V. N. (1974) Effect of lipoic acid on tissue respiration in rabbits with experimental atherosclerosis. Cor. Vasa. 16: 141-150.
36. Shih, J. C. (1983) Atherosclerosis in Japanese quail and the effect of lipoic acid. Fed. Proc. 42: 2494-2497.
37. Ford, I., Cotter, M. A., Cameron, N. E. & Greaves, M. (2001) The effects of treatment with α-lipoic acid or evening primrose oil on vascular haemostatic and lipid risk factors, blood flow, and peripheral nerve conduction in the streptozotocin-diabetic rat. Metabolism 50: 868-875.
38. Segermann, J., Hotze, A., Ulrich, H. & Rao, G. S. (1991) Effect of α-lipoic acid on the peripheral conversion of thyroxine to triiodothyronine and on serum lipid-, protein- and glucose levels. Arzneim.-Forsch. 41: 1294-1298.
39. Vasdev, S., Ford, C. A., Parai, S., Longerich, L. & Gadag, V. (2000) Dietary α-lipoic acid supplementation lowers blood pressure in spontaneously hypertensive rats. J. Hypertens. 18: 567-573.
40. Midaoui, A. & de Champlain, J. (2002) Prevention of hypertension, insulin resistance, and oxidative stress by α-lipoic acid. Hypertension 39: 303-307.